A detailed history of Capital International Investors transactions in Johnson & Johnson stock. As of the latest transaction made, Capital International Investors holds 5,070,550 shares of JNJ stock, worth $787 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,070,550
Previous 5,069,613 0.02%
Holding current value
$787 Million
Previous $741 Million 10.9%
% of portfolio
0.16%
Previous 0.16%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$145.48 - $167.38 $136,314 - $156,835
937 Added 0.02%
5,070,550 $822 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $1.75 Billion - $1.91 Billion
-12,086,268 Reduced 70.45%
5,069,613 $741 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $1.84 Billion - $1.93 Billion
-11,829,795 Reduced 40.81%
17,155,881 $2.71 Billion
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $79,060 - $86,271
-543 Reduced -0.0%
28,985,676 $4.54 Billion
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $181 Million - $202 Million
1,160,424 Added 4.17%
28,986,219 $4.51 Billion
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $1.66 Billion - $1.78 Billion
10,724,110 Added 62.71%
27,825,795 $4.61 Billion
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $70.7 Million - $84.4 Million
-467,969 Reduced 2.66%
17,101,685 $2.65 Billion
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $194 Million - $218 Million
-1,212,751 Reduced 6.46%
17,569,654 $3.1 Billion
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $118 Million - $131 Million
-728,840 Reduced 3.74%
18,782,405 $3.07 Billion
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $87.7 Million - $97 Million
-521,705 Reduced 2.6%
19,511,245 $3.46 Billion
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $27.4 Million - $31.1 Million
-173,269 Reduced 0.86%
20,032,950 $3.55 Billion
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $57 Million - $63.2 Million
-365,411 Reduced 1.78%
20,206,219 $3.46 Billion
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $229 Million - $254 Million
1,417,008 Added 7.4%
20,571,630 $3.32 Billion
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $139 Million - $149 Million
868,659 Added 4.75%
19,154,622 $3.16 Billion
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $2.1 Million - $2.34 Million
13,703 Added 0.07%
18,285,963 $3.01 Billion
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $1.63 Million - $1.87 Million
11,904 Added 0.07%
18,272,260 $2.88 Billion
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $2.42 Million - $2.66 Million
17,262 Added 0.09%
18,260,356 $2.72 Billion
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $195 Million - $236 Million
1,516,129 Added 9.06%
18,243,094 $2.57 Billion
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $223 Million - $309 Million
2,004,688 Added 13.62%
16,726,965 $2.19 Billion
Q4 2019

Feb 18, 2020

SELL
$127.5 - $146.44 $624 Million - $717 Million
-4,898,022 Reduced 24.96%
14,722,277 $2.15 Billion
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $302 Million - $338 Million
-2,375,078 Reduced 10.8%
19,620,299 $2.54 Billion
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $80.1 Million - $88.1 Million
-610,880 Reduced 2.7%
21,995,377 $3.06 Billion
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $304 Million - $338 Million
-2,417,554 Reduced 9.66%
22,606,257 $3.16 Billion
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $4.86 Million - $5.85 Million
39,562 Added 0.16%
25,023,811 $3.23 Billion
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $2.28 Billion - $2.68 Billion
18,768,905 Added 301.98%
24,984,249 $3.45 Billion
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $16,954 - $18,709
142 Added 0.0%
6,215,344 $754 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $12.1 Million - $14.4 Million
96,999 Added 1.59%
6,215,202 $796 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $84.2 Million - $92.1 Million
641,400 Added 11.71%
6,118,203 $855 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $709 Million - $741 Million
5,476,803
5,476,803 $712 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.